ဖလူစတက် ဆေးသည် ဘက်တီးရီးယား ပိုးသတ်ဆးအမျိုးအစားဖြစ်ပါသည်။
Flustaph is a penicillinase resistant semisynthetic isoxazylpencillin. It is gastric acid stable and active against Gram positive bacteria. Flustaph is a bactericidal antibiotic and kills the bacteria by interfering bacterial cell wall synthesis. Flustaph inhibits the final stage of synthesis of peptidoglycan, which provides the mechanical stability of bacterial cell wall by inhibiting the enzyme transpeptidase.
Flustaph is indicated to treat the infection caused by Gram positive organism, including beta-lactamase producing Staphylococci. Major indications include: Skin and soft tissue infection: Boils, abscesses, carbuncle, furunculosis, otitis exterma, impetigo and infected skin conditions such as ulcer, eczema and acne. Respiratory tract Infections: Pneumonia, lungs abscess, emphysema, sinusitis, pharyngitis, otitis media, tonsillitis and quinsy. Other infections caused by Gram positive Staphylococci such as: osteomyelitis, urinary tract infections, endocarditis, meningitis, and septicemia. Flustaph can also be used as prophylactic agent during major surgical procedures such as cardiothoracic and orthopedic surgery.